Fosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore via a block deal, reducing its holding to 45.77%. Major buyers included Kotak, Axis, and ICICI Prudential Mutual Funds, while Gland Pharma shares closed higher at ₹2,932.40.
eMudhra shares crash another 4%, down 40% in 3 sessions. What’s behind this free fall?
eMudhra will exit its global SSL/TLS certificate business following a security incident involving compromised private keys linked to eight intermediate Certificate Authority certificates. The segment